Immune Pharmaceuticals (IMNP) PT Raised to $6.50 at Chardan Capital Markets Oct 13, 2015 07:36AM
Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors Jul 29, 2015 04:15PM
Immune Pharma (IMNP) Announces Date to Commence Bertilimumab Phase II Bullous Pemphigoid Trial Jun 25, 2015 04:33PM
Immune Pharmaceuticals Initiates Phase II Clinical Trials With Bertilimumab In Ulcerative Colitis And Bullous Pemphigoid Jun 25, 2015 04:30PM
Chardan Capital Lifts PT on Immune Pharma (IMNP) to $6 Following Q1 Report; AmiKet Appears on Track May 18, 2015 10:14AM


Mar 9, 2015 08:06AM Chardan Capital Markets Starts Immune Pharmaceuticals (IMNP) at Buy; $5.50 PT
May 14, 2014 08:17AM Chardan Capital Markets Starts Immune Pharmaceuticals (IMNP) at Buy, $11 PT